E Muraro, M De Zorzi, G Miolo, D Lombardi… - Frontiers in …, 2022 - frontiersin.org
Trastuzumab induced a high rate of pathological Complete Response (pCR) in patients
affected by locally advanced HER2-positive Breast Cancer (HER2-BC), by exploiting …